Astex Pharmaceuticals Responds to Further Misleading Claims Made by Sarissa Capital
Published: Oct 10, 2013
DUBLIN, Calif., Oct. 9, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX) ("Astex"), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, issued the following statement in response to further misleading claims made by Sarissa Capital in a press release issued earlier today:
Help employers find you! Check out all the jobs and post your resume.